Shengtai Pharmaceutical Inc  

(Public, OTCMKTS:SGTI)   Watch this stock  
Find more results for SGTI
0.000 (0.00%)
Aug 24 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.07 - 0.29
Open     -
Vol / Avg. 0.00/750.00
Mkt cap 1.34M
P/E     -
Div/yield     -
EPS     -
Shares 9.58M
Beta -0.41
Inst. own 16%

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 0.21% 0.60%
Operating margin 2.99% 3.07%
EBITD margin - 7.57%
Return on average assets 0.23% -
Return on average equity 0.66% -
Employees 733 -
CDP Score - -


Changda Road East Development District, Changle County
+86-536-2188831 (Phone)

Website links


Shengtai Pharmaceutical, Inc. (Shengtai) through its direct and indirect subsidiaries in China, manufactures and distributes glucose and starch as pharmaceutical raw materials, other starch products and other glucose products, such as corn meals, food and beverage glucose and dextrin. The Company's primary business operations are conducted in the People's Republic of China. Shengtai manufactures products in three categories: raw materials for pharmaceutical and medicinal companies or purposes, raw materials for the food and beverage industries and other products. Approximately 49.08% of its revenues during the fiscal year ended June 30, 2010 (fiscal 2010), were attributable to sales of glucose products. Approximately 26.43% of its sales revenues for fiscal 2010 were attributable to sales of starch products.

Officers and directors

Qingtai Liu Chairman of the Board, Chief Executive Officer
Age: 55
Yongqiang Wang Chief Financial Officer, Director
Age: 43
Tao Jin Independent Director
Age: 44
Lawrence Lee Independent Director
Age: 50
Yaojun Liu Independent Director
Age: 36